01—History
Income Tax Expense History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $54.0M
5 older moves run past ±150% (largest +36000.0%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is income tax expense?
Income tax expense is the total amount of income taxes a company owes to federal, state, and foreign governments.
What is Moderna, Inc.'s current income tax expense?
Moderna, Inc. (MRNA) annual income tax expense for 2025 was $54.0M, a 217.39% increase from 2024. Moderna, Inc. income tax expense for the quarter ending March 31, 2026 was $9.0M.
What was Moderna, Inc.'s income tax expense in 2024?
Moderna, Inc. annual income tax expense for 2024 was $-46.0M, a 105.96% decline from 2023.
What was Moderna, Inc.'s income tax expense in 2023?
Moderna, Inc. annual income tax expense for 2023 was $772.0M, a 36.36% decline from 2022.
What is Moderna, Inc.'s 5-year income tax expense CAGR?
Moderna, Inc. income tax expense grew at a compound annual growth rate (CAGR) of 78.26% from FY2020 to FY2025, going from $3.0M to $54.0M over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)